NL-OMON29203Other不适用
Comparing tumour heterogeneity in primary tumour, circulating tumour cells and metastases
niversity Medical Centre Groningen0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- Other
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Patients with a histologically/cytologically proven pulmonary malignancy.
- •2.Patients have to have a non-curable disease state, without curative treatment options
排除标准
- •1.No growth factor medication
研究者
相似试验
尚未招募
不适用
Comparing tumour heterogeneity in primary tumour, circulating tumour cells and its metastaseslungcancer1002765510029107NL-OMON45251niversitair Medisch Centrum Groningen50
招募中
不适用
Characterisation of tumour heterogeneity and identification of adaptive resistance mechanisms of metastatic castration-resistant prostate carcinomaC61Malignant neoplasm of prostateDRKS00028021Klinik für Nuklearmedizin am Universitätsklinikum Augsburg45
招募中
2 期
Tumour heterogeneity studies based on dedicated breast PET using proliferation radiotracers: early detection of the treatment response.Breast cancer2024-512152-38-00Fundacion Instituto De Investigacion Sanitaria De Santiago De Compostela100
尚未招募
Unknown
Fluorodeoxyglucose (FDG) and human epidermal growth factor receptor 2 (HER2) positron emission tomography (PET) scan in breast cancerCancer - BreastBreast cancerACTRN12624000918527Fiona Stanley Hospital10
招募中
不适用
Value of 7 Tesla in gliomasHigh grade and low grade gliomaNL-OMON24352Medical Delta25